[Cholysarkosin in treatment of bile acid deficiency syndrome].
Weinand
I
I
Medizinische Klinik II, Johann-Wolfgang-Goethe-Universität, Frankfurt.
Stein
J
J
D000284:Administration, Oral; D001647:Bile Acids and Salts / Q000172:deficiency*; D002446:Celiac Disease / Q000188:drug therapy / Q000209:etiology; D002793:Cholic Acids / Q000008:administration & dosage* / Q000009:adverse effects; D003967:Diarrhea / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007082:Ileum / Q000601:surgery*; D007408:Intestinal Absorption / Q000187:drug effects; D008286:Malabsorption Syndromes / Q000188:drug therapy* / Q000209:etiology; D012521:Sarcosine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D012778:Short Bowel Syndrome / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome
D001647:Bile Acids and Salts; D002793:Cholic Acids; C061997:cholylsarcosine; D012521:Sarcosine